|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/18 British American Tobacco p.l.c. 20-F 12/31/17 233:140M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual Report by a Foreign Non-Canadian Issuer HTML 6.02M
2: EX-2.4 Plan of Acquisition, Reorganization, Arrangement, HTML 736K
Liquidation or Succession
3: EX-2.5 Plan of Acquisition, Reorganization, Arrangement, HTML 164K
Liquidation or Succession
4: EX-2.7 Plan of Acquisition, Reorganization, Arrangement, HTML 112K
Liquidation or Succession
5: EX-4.12 Instrument Defining the Rights of Security Holders HTML 128K
6: EX-4.13 Instrument Defining the Rights of Security Holders HTML 128K
7: EX-4.14 Instrument Defining the Rights of Security Holders HTML 128K
8: EX-4.15 Instrument Defining the Rights of Security Holders HTML 128K
9: EX-4.16 Instrument Defining the Rights of Security Holders HTML 128K
10: EX-4.17 Instrument Defining the Rights of Security Holders HTML 128K
11: EX-4.18 Instrument Defining the Rights of Security Holders HTML 128K
12: EX-4.19 Instrument Defining the Rights of Security Holders HTML 127K
13: EX-4.20 Instrument Defining the Rights of Security Holders HTML 127K
14: EX-4.21 Instrument Defining the Rights of Security Holders HTML 127K
17: EX-13 Annual or Quarterly Report to Security Holders HTML 67K
15: EX-11 Statement re: Computation of Earnings Per Share HTML 71K
16: EX-12 Statement re: Computation of Ratios HTML 79K
18: EX-15 Letter re: Unaudited Interim Financial Info HTML 67K
25: R1 Document and Entity Information HTML 94K
26: R2 Group Income Statement HTML 126K
27: R3 Group Income Statement (Parenthetical) HTML 70K
28: R4 Group Statement of Comprehensive Income HTML 147K
29: R5 Group Statement of Changes in Equity HTML 123K
30: R6 Group Balance Sheet HTML 177K
31: R7 Group Cash Flow Statement HTML 166K
32: R8 Accounting policies HTML 150K
33: R9 Segmental analyses HTML 1.91M
34: R10 Profit from operations HTML 460K
35: R11 Net finance costs/(Income) HTML 231K
36: R12 Associates and joint ventures HTML 838K
37: R13 Taxation on ordinary activities HTML 531K
38: R14 Earnings per share HTML 1.73M
39: R15 Dividends and other appropriations HTML 305K
40: R16 Intangible assets HTML 745K
41: R17 Property, plant and equipment HTML 654K
42: R18 Investments in associates and joint ventures HTML 303K
43: R19 Retirement benefit schemes HTML 2.46M
44: R20 Deferred tax HTML 405K
45: R21 Trade and other receivables HTML 238K
46: R22 Available-for-sale investments HTML 139K
47: R23 Derivative financial instruments HTML 923K
48: R24 Inventories HTML 106K
49: R25 Cash and cash equivalents HTML 172K
50: R26 Capital and reserves - reconciliation of movement HTML 4.34M
in total equity
51: R27 Borrowings HTML 1.15M
52: R28 Provisions for liabilities HTML 411K
53: R29 Trade and other payables HTML 150K
54: R30 Financial instruments and risk management HTML 587K
55: R31 Business combinations, disposals and other changes HTML 146K
in the Group
56: R32 Share-based payments HTML 613K
57: R33 Group employees HTML 132K
58: R34 Related party disclosures HTML 788K
59: R35 Contingent liabilities and financial commitments HTML 513K
60: R36 Interests in subsidiaries HTML 278K
61: R37 Condensed consolidating financial information HTML 5.89M
62: R38 Accounting policies (Policies) HTML 196K
63: R39 Segmental analyses (Tables) HTML 1.91M
64: R40 Profit from operations (Tables) HTML 441K
65: R41 Net Finance Costs/(Income) (Tables) HTML 224K
66: R42 Associates and joint ventures (Tables) HTML 831K
67: R43 Taxation on ordinary activities (Tables) HTML 522K
68: R44 Earnings per share (Tables) HTML 1.73M
69: R45 Dividends and other appropriations (Tables) HTML 302K
70: R46 Intangible assets (Tables) HTML 735K
71: R47 Property, plant and equipment (Tables) HTML 654K
72: R48 Investments in associates and joint ventures HTML 302K
(Tables)
73: R49 Retirement Benefit Schemes (Tables) HTML 2.44M
74: R50 Deferred tax (Tables) HTML 397K
75: R51 Trade and Other Receivables (Tables) HTML 239K
76: R52 Available-for-sale investments (Tables) HTML 137K
77: R53 Derivative Financial Instruments (Tables) HTML 921K
78: R54 Inventories (Tables) HTML 104K
79: R55 Cash and cash equivalents (Tables) HTML 174K
80: R56 Capital and reserves - reconciliation of movement HTML 4.34M
in total equity (Tables)
81: R57 Borrowings (Tables) HTML 1.16M
82: R58 Provisions for liabilities (Tables) HTML 404K
83: R59 Trade and other payables (Tables) HTML 147K
84: R60 Financial instruments and risk management (Tables) HTML 554K
85: R61 Business combinations, disposals and other changes HTML 129K
in the Group (Tables)
86: R62 Share-based Payments (Tables) HTML 611K
87: R63 Group Employees (Tables) HTML 128K
88: R64 Related Party Disclosures (Tables) HTML 784K
89: R65 Contingent liabilities and financial commitments HTML 291K
(Tables)
90: R66 Interests in subsidiaries (Tables) HTML 274K
91: R67 Condensed consolidating financial information HTML 5.89M
(Tables)
92: R68 Accounting policies - Additional Information HTML 99K
(Details)
93: R69 Segmental Analyses - Disclosure of Revenues at HTML 129K
Current Rates and Revenues Translated (Details)
94: R70 Segmental Analyses - Additional Information HTML 104K
(Details)
95: R71 Segmental Analyses - Disclosure of Operating HTML 217K
Segment Information (Details)
96: R72 Segmental Analyses - Summary of Depreciation HTML 132K
Amortisation and Impairment Charges (Details)
97: R73 Segmental Analyses - Disclosure of Geographical HTML 84K
Information of External Revenue (Details)
98: R74 Profit from Operations - Summary of Employee HTML 79K
Benefit Costs (Details)
99: R75 Profit from Operations - Summary of Depreciation HTML 81K
Amortisation and Impairment Costs (Details)
100: R76 Profit from Operations - Summary of Other HTML 110K
Operating Expenses (Details)
101: R77 Profit from Operations - Other Operating Expenses HTML 94K
- Additional Information (Details)
102: R78 Profit from Operations - Master Settlements HTML 81K
Agreement - Additional Information (Details)
103: R79 Profit from Operations - Summary Costs of HTML 85K
Integrating Acquired Businesses into Existing
Operations (Details)
104: R80 Profit from Operations - Restructuring and HTML 75K
Integration Costs - Additional Information
(Details)
105: R81 Profit from Operations - Fox River - Additional HTML 100K
Information (Details)
106: R82 Profit from Operations - Other Adjusting Items - HTML 81K
Additional Information (Details)
107: R83 Profit from Operations - Flintkote - Additional HTML 72K
Information (Details)
108: R84 Net Finance Costs/(Income) - Summary of Net HTML 101K
Finance Costs/(Income) (Details)
109: R85 Net Finance Costs/(Income) - Additional HTML 94K
Information (Details)
110: R86 Associates and Joint Ventures - Schedule of Profit HTML 122K
Loss of Associates and Joint Ventures Accounted
for Using Equity Method (Details)
111: R87 Associates and Joint Ventures - Additional HTML 142K
Information (Details)
112: R88 Associates and Joint Ventures - Summary of Group's HTML 89K
Share of the Result of Associates and Joint
Ventures (Details)
113: R89 Associates and Joint Ventures - Summary of HTML 109K
Financial Information of the Group's Associates
and Joint Ventures (Details)
114: R90 Taxation on Ordinary Activities - Summary of HTML 93K
Taxation on Ordinary Activities (Details)
115: R91 Taxation on Ordinary Activities - Additional HTML 119K
Information (Details)
116: R92 Taxation on Ordinary Activities - Summary of HTML 139K
Factors Affecting the Taxation Charge (Details)
117: R93 Taxation on Ordinary Activities - Summary of HTML 73K
Factors Affecting the Taxation Charge
(Parenthetical) (Details)
118: R94 Taxation on Ordinary Activities - Summary of Tax HTML 75K
on Items Recognised Directly in Other
Comprehensive Income (Details)
119: R95 Earnings Per Share - Summary of Earnings Per Share HTML 87K
(Details)
120: R96 Earnings Per Share - Summary of Earnings Per Share HTML 69K
(Parenthetical) (Details)
121: R97 Earnings Per Share - Summary of Adjusted Earnings HTML 243K
Per Share (Details)
122: R98 Earnings Per Share - Summary of Headline Earnings HTML 183K
Per Share (Details)
123: R99 Dividends and Other Appropriations - Summary of HTML 74K
Detailed Information About Dividends (Details)
124: R100 Dividends and Other Appropriations - Additional HTML 81K
Information (Details)
125: R101 Intangible Assets - Schedule of Movement In HTML 121K
Intangible Assets (Details)
126: R102 Intangible Assets - Additional Information HTML 153K
(Details)
127: R103 Intangible Assets - Schedule of Cash Generating HTML 102K
Unit (Details)
128: R104 Property, Plant and Equipment - Schedule of HTML 133K
Property, Plant and Equipment (Details)
129: R105 Property, Plant and Equipment - Additional HTML 82K
Information (Details)
130: R106 Property, Plant and Equipment - Schedule of Cost HTML 87K
of Freehold Land, Net Book Value of Leasehold
Properties and Contracts Placed for Future
Expenditure (Details)
131: R107 Investments in Associates and Joint Ventures - HTML 123K
Summary of Investments In Associates And Joint
Ventures (Details)
132: R108 Investments in Associates and Joint Ventures - HTML 78K
Summary of Investments In Associates And Joint
Ventures (Parenthetical) (Details)
133: R109 Investments in Associates and Joint Ventures - HTML 105K
Additional Information (Details)
134: R110 Investments in Associates and Joint Ventures - HTML 93K
Summary of Principal Associate Undertakings
(Details)
135: R111 Investments in Associates and Joint Ventures - HTML 75K
Summary of Principal Associate Undertakings
(Parenthetical) (Details)
136: R112 Investments in Associates and Joint Ventures - HTML 100K
Summary of Latest Published Information (Details)
137: R113 Investments in Associates and Joint Ventures - HTML 72K
Summary of Latest Published Information
(Parenthetical) (Details)
138: R114 Retirement Benefit Schemes - Additional HTML 174K
Information (Details)
139: R115 Retirement Benefit Schemes - Schedule of Defined HTML 105K
Benefit Amounts Recognised in Balance Sheets
(Details)
140: R116 Retirement Benefit Schemes - Schedule of Defined HTML 80K
Net Liability Recognised in Balance Sheets
(Details)
141: R117 Retirement Benefit Schemes - Schedule of Net HTML 100K
Liabilities of Funded Pension Schemes by Territory
(Details)
142: R118 Retirement Benefit Schemes - Schedule of Defined HTML 94K
Benefit Amounts Recognised in Income Statement
(Details)
143: R119 Retirement Benefit Schemes - Schedule of Movements HTML 112K
in Scheme Liabilities (Details)
144: R120 Retirement Benefit Schemes - Schedule of Scheme HTML 87K
Liabilities by Scheme Membership (Details)
145: R121 Retirement Benefit Schemes - Summary of Movements HTML 123K
in Funded Scheme Assets (Details)
146: R122 Retirement Benefit Schemes - Summary of Movements HTML 81K
in the Unrecognised Scheme Surpluses Recognised in
Other Comprehensive Income (Details)
147: R123 Retirement Benefit Schemes - Summary of Actuarial HTML 103K
Assumptions Rate for Valuations Plans (Details)
148: R124 Retirement Benefit Schemes - Summary of Principal HTML 83K
Schemes Used (Details)
149: R125 Retirement Benefit Schemes - Summary of Weighted HTML 93K
Average Life Expectancy Used to Determine Benefit
Obligations (Details)
150: R126 Retirement Benefit Schemes - Summary of HTML 81K
Sensitivity Analysis (Details)
151: R127 Deferred Tax - Summary of Reconciliation of Net HTML 114K
Deferred Tax Assets/(Liabilities) (Details)
152: R128 Deferred Tax - Additional Information (Details) HTML 116K
153: R129 Trade and Other Receivables - Summary of Trade and HTML 83K
Other Receivables (Details)
154: R130 Trade and Other Receivables - Additional HTML 88K
Information (Details)
155: R131 Trade and Other Receivables - Summary of Trade and HTML 75K
Other Receivables Reported in Balance Sheet Net of
Allowances (Details)
156: R132 Trade and Other Receivables - Summary of Movements HTML 79K
in Allowance Account (Details)
157: R133 Trade and Other Receivables - Summary of Aged HTML 82K
Analysis of Trade Receivables (Details)
158: R134 Available-for-sale Investments - Schedule of HTML 88K
Available-for-sale Investments (Details)
159: R135 Derivative Financial Instruments - Summary of HTML 110K
Derivatives (Details)
160: R136 Derivative Financial Instruments - Additional HTML 79K
Information (Details)
161: R137 Derivative Financial Instruments - Summary of HTML 100K
Maturity Dates of Gross-settled Derivative
Financial Instruments (Details)
162: R138 Derivative Financial Instruments - Summary of HTML 88K
Maturity Dates of Net-settled Derivative Financial
Instruments (Details)
163: R139 Inventories - Summary of Inventories (Details) HTML 76K
164: R140 Inventories - Additional Information (Details) HTML 73K
165: R141 Cash and Cash Equivalents - Schedule Representing HTML 75K
Cash and Cash Equivalents (Details)
166: R142 Cash and Cash Equivalents - Summary of Cash and HTML 79K
Cash Equivalents Denominated in the Functional
Currency of the Subsidiary Undertaking or Other
Currencies (Details)
167: R143 Cash and Cash Equivalents - Summary of Net Cash HTML 76K
and Cash Equivalents Shown After Deducting Bank
Overdrafts and Accrued Interest (Details)
168: R144 Cash and Cash Equivalents - Additional Information HTML 70K
(Details)
169: R145 Capital and Reserves - Reconciliation of Movement HTML 214K
in Total Equity - Summary of Capital and Reserves
- Reconciliation of Movement in Total Equity
(Details)
170: R146 Capital and Reserves - Reconciliation of Movement HTML 83K
in Total Equity - Summary of Composition of Share
Premium Account, Capital Redemption Reserves and
Merger Reserves (Details)
171: R147 Capital and Reserves - Reconciliation of Movement HTML 136K
in Total Equity - Additional Information (Details)
172: R148 Capital and Reserves - Reconciliation of Movement HTML 83K
in Total Equity - Summary of Movements of Called
Up Share Capital (Details)
173: R149 Capital and Reserves - Reconciliation of Movement HTML 72K
in Total Equity - Summary of Movements of Called
Up Share Capital (Parenthetical) (Details)
174: R150 Capital and Reserves - Reconciliation of Movement HTML 201K
in Total Equity - Summary of Movements in Other
Reserves and Retained Earnings (Details)
175: R151 Capital and Reserves - Reconciliation of Movement HTML 90K
in Total Equity - Summary of Tax Attributable to
Components of Other Comprehensive Income (Details)
176: R152 Borrowings - Schedule of Detailed Information HTML 129K
About Borrowings (Details)
177: R153 Borrowings - Additional Information (Details) HTML 118K
178: R154 Borrowings - Schedule of Detailed Information HTML 92K
About Repayment of Borrowings (Details)
179: R155 Borrowings - Schedule of Analysis of Borrowings by HTML 105K
Currency (Details)
180: R156 Borrowings - Schedule of Analysis of Borrowings by HTML 112K
Interest Rate Changes (Details)
181: R157 Borrowings - Schedule of Analysis of Net Debt HTML 81K
(Details)
182: R158 Borrowings - Schedule of Analysis of Net Debt HTML 71K
(Parenthetical) (Details)
183: R159 Borrowings - Schedule of Analysis of Net Debt HTML 92K
Movements (Details)
184: R160 Provisions for liabilities - Summary of Provisions HTML 101K
Excluding Post-Retirement Benefits (Details)
185: R161 Provisions for liabilities - Additional HTML 100K
Information (Details)
186: R162 Trade and Other Payables - Summary of Trade and HTML 86K
Other Payables (Details)
187: R163 Trade and Other Payables - Additional Information HTML 76K
(Details)
188: R164 Financial Instruments and Risk Management - HTML 300K
Additional Information (Details)
189: R165 Financial Instruments and Risk Management - HTML 99K
Summary of Assets and Liabilities Measured at Fair
Value (Details)
190: R166 Financial Instruments and Risk Management - HTML 79K
Summary of Derivative Financial Asset and
Liabilities Offsetting Arrangements (Details)
191: R167 Business Combinations, Disposals and Other Changes HTML 293K
in the Group - Additional Information (Details)
192: R168 Business Combinations, Disposals and Other Changes HTML 116K
in the Group - Schedule of Fair Values Assigned to
the Asset Acquired and Liabilities Assumed on
Acquisition Date (Details)
193: R169 Business Combinations, Disposals and Other Changes HTML 76K
in the Group - Schedule of Fair Values Assigned to
the Asset Acquired and Liabilities Assumed on
Acquisition Date (Parenthetical) (Details)
194: R170 Share-based Payments - Additional Information HTML 152K
(Details)
195: R171 Share-based Payments - Summary of Share-based HTML 88K
Payment Expense (Details)
196: R172 Share-based Payments - Summary of Share-based HTML 84K
Payment Liability (Details)
197: R173 Share-based Payments - Summary of Movements for HTML 89K
Equity and Cash-Settled LTIP Scheme (Details)
198: R174 Share-based Payments - Summary of Movements for HTML 88K
Equity and Cash-Settled DSBS Scheme (Details)
199: R175 Share-based Payments - Valuation Assumptions HTML 88K
(Details)
200: R176 Share-based Payments - Summary of Valuation HTML 73K
Assumptions Used in Models (Details)
201: R177 Group Employees - Additional Information (Details) HTML 70K
202: R178 Group Employees - Summary of Average Number of HTML 85K
Persons Employed by Group and Associates (Details)
203: R179 Related Party Disclosures - Additional information HTML 121K
(Details)
204: R180 Related Party Disclosures - Summary of HTML 81K
Transactions Between Related Parties (Details)
205: R181 Related Party Disclosures - Summary of Amounts HTML 114K
Incurred by Entity for Provision of Key Management
Personnel Services (Details)
206: R182 Related Party Disclosures - Summary of Aggregate HTML 96K
Gains on LTIP Shares Exercised (Details)
207: R183 Related Party Disclosures - Summary of Aggregate HTML 74K
Gains on LTIP Shares Exercised (Parenthetical)
(Details)
208: R184 Contingent Liabilities and Financial Commitments - HTML 74K
General Litigation Overview - Additional
Information (Details)
209: R185 Contingent Liabilities and Financial Commitments - HTML 173K
US Litigation - Additional Information (Details)
210: R186 Contingent Liabilities and Financial Commitments - HTML 152K
Engle Class Action and Engle Progeny Cases -
Additional Information (Details)
211: R187 Contingent Liabilities and Financial Commitments - HTML 83K
Summary of Engle Progeny Cases (Details)
212: R188 Contingent Liabilities and Financial Commitments - HTML 86K
Summary of Engle Progeny Cases (Parenthetical)
(Details)
213: R189 Contingent Liabilities and Financial Commitments - HTML 87K
Summary of Individual Cases (Details)
214: R190 Contingent Liabilities and Financial Commitments - HTML 115K
Summary of Individual Cases (Parenthetical)
(Details)
215: R191 Contingent Liabilities and Financial Commitments - HTML 81K
Operating Subsidiaries' Expenses and Payments
under State Settlement Agreements (Details)
216: R192 Contingent Liabilities and Financial Commitments - HTML 214K
Product Liability Outside the United States -
Additional Information (Details)
217: R193 Contingent Liabilities and Financial Commitments - HTML 110K
Summary of Current Status of Litigation Cases
(Details)
218: R194 Contingent Liabilities and Financial Commitments - HTML 209K
Non-Tobacco Related Litigation - Additional
Information (Details)
219: R195 Contingent Liabilities and Financial Commitments - HTML 88K
Closed Litigation Matters Explanatory (Details)
220: R196 Contingent Liabilities and Financial Commitments - HTML 83K
Other contingencies - Additional Information
(Details)
221: R197 Contingent Liabilities and Financial Commitments - HTML 87K
Tax Disputes - Additional Information (Details)
222: R198 Contingent Liabilities and Financial Commitments - HTML 84K
Schedule of Total Future Minimum Lease Payments
under Non-cancellable Operating Leases (Details)
223: R199 Contingent Liabilities and Financial Commitments - HTML 76K
Performance Guarantees - Additional Information
(Details)
224: R200 Interests in Subsidiaries - Additional Information HTML 87K
(Details)
225: R201 Interests in Subsidiaries - Summary of Financial HTML 143K
Information of Subsidiaries with Material
Non-controlling Interests (Details)
226: R202 Condensed consolidating financial information - HTML 73K
Additional Information (Details)
227: R203 Condensed consolidating financial information - HTML 166K
Condensed Consolidated Income Statement (Details)
228: R204 Condensed consolidating financial information - HTML 156K
Condensed Consolidated Statement of Comprehensive
Income (Details)
229: R205 Condensed consolidating financial information - HTML 257K
Condensed Consolidated Balance Sheet (Details)
230: R206 Condensed consolidating financial information - HTML 116K
Condensed Consolidated Cash Flow Statement
(Details)
232: XML IDEA XML File -- Filing Summary XML 455K
231: EXCEL IDEA Workbook of Financial Reports XLSX 337K
19: EX-101.INS XBRL Instance -- bti-20171231 XML 58.91M
21: EX-101.CAL XBRL Calculations -- bti-20171231_cal XML 666K
22: EX-101.DEF XBRL Definitions -- bti-20171231_def XML 3.36M
23: EX-101.LAB XBRL Labels -- bti-20171231_lab XML 4.32M
24: EX-101.PRE XBRL Presentations -- bti-20171231_pre XML 4.15M
20: EX-101.SCH XBRL Schema -- bti-20171231 XSD 973K
233: ZIP XBRL Zipped Folder -- 0001193125-18-083410-xbrl Zip 1.27M
| EX-12 |
EXHIBIT 12
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
| I, | Nicandro Durante, certify that: |
| 1. | I have reviewed this annual report on Form 20-F of British American Tobacco p.l.c.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
| 4. | The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | [Paragraph omitted in accordance with Exchange Act Rule 13a-14(a)]; |
| (c) | Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and |
| 5. | The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: 15 March 2018
| /s/ Nicandro Durante | ||
| Chief Executive |
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
| I, | John Benedict Stevens, certify that: |
| 1. | I have reviewed this annual report on Form 20-F of British American Tobacco p.l.c.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
| 4. | The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | [Paragraph omitted in accordance with Exchange Act Rule 13a-14(a)]; |
| (c) | Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and |
| 5. | The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: 15 March 2018
| Finance Director |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/09/24 British American Tobacco p.l.c. 20-F 12/31/23 244:296M 3/02/23 British American Tobacco p.l.c. 20-F 12/31/22 233:193M 7/01/22 British American Tobacco p.l.c. F-3ASR 7/01/22 13:3.3M Donnelley … Solutions/FA 3/08/22 British American Tobacco p.l.c. 20-F 12/31/21 248:128M Donnelley … Solutions/FA 3/09/21 British American Tobacco p.l.c. 20-F 12/31/20 232:119M Donnelley … Solutions/FA 7/23/18 SEC UPLOAD¶ 8/20/18 1:44K British American Tobacco p.l.c. 6/13/18 SEC UPLOAD¶ 8/20/18 1:46K British American Tobacco p.l.c. 5/16/18 SEC UPLOAD¶ 8/20/18 1:50K British American Tobacco p.l.c. |